Next Article in Journal
Minimally Invasive Salvage Approaches for Management of Recurrence After Primary Renal Mass Ablation
Previous Article in Journal
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study
 
 
Review

Article Versions Notes

Cancers 2025, 17(6), 973; https://doi.org/10.3390/cancers17060973
Action Date Notes Link
article xml file uploaded 13 March 2025 13:57 CET Original file -
article xml uploaded. 13 March 2025 13:57 CET Update -
article pdf uploaded. 13 March 2025 13:57 CET Version of Record https://www.mdpi.com/2072-6694/17/6/973/pdf-vor
article html file updated 13 March 2025 13:58 CET Original file -
article xml file uploaded 20 March 2025 10:58 CET Update -
article xml uploaded. 20 March 2025 10:58 CET Update https://www.mdpi.com/2072-6694/17/6/973/xml
article pdf uploaded. 20 March 2025 10:58 CET Updated version of record https://www.mdpi.com/2072-6694/17/6/973/pdf
article html file updated 20 March 2025 10:59 CET Update https://www.mdpi.com/2072-6694/17/6/973/html
Back to TopTop